Literature DB >> 2971844

Analysis of immunocompetent cells following inner ear immunostimulation.

M Takahashi1, J P Harris.   

Abstract

Immunohistochemical methods were used to investigate the development of inner ear immunocompetent cells in healthy, BALB/c mice over a 3-week period as a result of a secondary inner ear response against keyhole limpet hemocyanin. Antibodies against murine macrophages and granulocytes (anti-Mac-1), T-cells (anti-Lyt-1, anti-Lyt-2), and immunoglobulins (anti-IgM, anti-IgG, anti-IgA) were used. Mac-1 positive (Mac-1+) cells were observed at 6 hours post-challenge in the endolymphatic sac and cochlea and rapidly increased in both sites. Lyt-1+ cells gradually increased in the endolymphatic sac after challenge, peaking at 2 and 3 weeks post-challenge. In the cochlea, Lyt-1+ cells were detected at 1 day post-challenge and then increased. Lyt-2+ cells were detectable in the endolymphatic sac and the cochlea by 3 weeks post-challenge. The predominant immunoglobulin-bearing cell in the endolymphatic sac was IgG, followed by IgM, with IgA seen late in the response. We conclude that the inner ear has the capacity to mount an immune response through the accumulation of the needed immunocompetent cells for antigen processing, antibody production, and modulation of the response through T-helper and suppressor cell activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2971844     DOI: 10.1288/00005537-198810000-00018

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  10 in total

Review 1.  Immune cells and non-immune cells with immune function in mammalian cochleae.

Authors:  Bo Hua Hu; Celia Zhang; Mitchell D Frye
Journal:  Hear Res       Date:  2017-12-20       Impact factor: 3.208

2.  Acoustic trauma augments the cochlear immune response to antigen.

Authors:  Masumichi Miyao; Gary S Firestein; Elizabeth M Keithley
Journal:  Laryngoscope       Date:  2008-10       Impact factor: 3.325

Review 3.  Immunosuppressive therapy for autoimmune inner ear disease.

Authors:  Maria C Buniel; Katie Geelan-Hansen; Peter C Weber; Vincent K Tuohy
Journal:  Immunotherapy       Date:  2009-05       Impact factor: 4.196

4.  Activation of the antigen presentation function of mononuclear phagocyte populations associated with the basilar membrane of the cochlea after acoustic overstimulation.

Authors:  W Yang; R R Vethanayagam; Y Dong; Q Cai; B H Hu
Journal:  Neuroscience       Date:  2015-06-20       Impact factor: 3.590

5.  Detection of cochlear dysfunction by the measurement of transiently evoked otoacoustic emissions in guinea pigs with autoimmune-induced labyrinthitis.

Authors:  U H Ross; M Rogowski; G Reiss; B Gloddek
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

6.  Proinflammatory cytokine expression in the endolymphatic sac during inner ear inflammation.

Authors:  Hitoshi Satoh; Gary S Firestein; Peter B Billings; Jeffrey P Harris; Elizabeth M Keithley
Journal:  J Assoc Res Otolaryngol       Date:  2003-06

Review 7.  Emerging options in immune-mediated hearing loss.

Authors:  Hitomi Sakano; Jeffrey P Harris
Journal:  Laryngoscope Investig Otolaryngol       Date:  2018-12-03

8.  The Human Endolymphatic Sac and Inner Ear Immunity: Macrophage Interaction and Molecular Expression.

Authors:  Charlotta Kämpfe Nordström; Niklas Danckwardt-Lillieström; Göran Laurell; Wei Liu; Helge Rask-Andersen
Journal:  Front Immunol       Date:  2019-02-01       Impact factor: 7.561

Review 9.  Distribution of Immune Cells Including Macrophages in the Human Cochlea.

Authors:  Wei Liu; Niklas Danckwardt-Lillieström; Anneliese Schrott-Fischer; Rudolf Glueckert; Helge Rask-Andersen
Journal:  Front Neurol       Date:  2021-11-22       Impact factor: 4.003

Review 10.  The Role of Autoimmunity in the Pathogenesis of Sudden Sensorineural Hearing Loss.

Authors:  Guangfei Li; Dan You; Jiaoyao Ma; Wen Li; Huawei Li; Shan Sun
Journal:  Neural Plast       Date:  2018-06-13       Impact factor: 3.599

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.